CNB would also have to be a UG operation and would require the CAPEX of a plant (most likely). I believe in-situ metal might be similar equivalents too.
Conversely AW1 would be a UC operation, not require plant CAPEX and has similar in-situ metal in the ground.
All without the motherlode.
- Forums
- ASX - By Stock
- AW1
- Ann: Trading Halt
Ann: Trading Halt, page-192
-
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AW1 (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.53M |
Open | High | Low | Value | Volume |
11.5¢ | 11.5¢ | 11.5¢ | $36.91K | 321.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 87999 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 684583 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 175000 | 0.120 |
6 | 288000 | 0.115 |
9 | 886517 | 0.110 |
5 | 531350 | 0.105 |
9 | 777200 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 151025 | 2 |
0.120 | 684583 | 4 |
0.125 | 699594 | 7 |
0.130 | 191703 | 7 |
0.135 | 1164640 | 8 |
Last trade - 10.00am 16/07/2024 (20 minute delay) ? |
Featured News
AW1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online